default author photo

Dhiraj Hans

University of Melbourne

Carlton

Parkville, 3010

Australia

SCHOLARLY PAPERS

1

DOWNLOADS

118

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Preclinical Evaluation of a Cross-Protective ß-SARS-CoV-2 Virus-Like Particle Vaccine Adjuvanted with MF59

Number of pages: 52 Posted: 26 Mar 2024
University of Melbourne - Department of Microbiology and Immunology (DMI), University of New South Wales (UNSW), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI), La Trobe University - Department of Biochemistry & Chemistry, The Walter and Eliza Hall Institute of Medical Research, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Royal Melbourne Hospital, SingHealth Duke-NUS Global Health Institute, Duke-NUS Medical School - Programme in Emerging Infectious Diseases, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, University of Melbourne - Royal Melbourne Hospital, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne, The Walter and Eliza Hall Institute of Medical Research, University of Melbourne, University of Melbourne - Department of Microbiology and Immunology (DMI), University of Melbourne - Department of Microbiology and Immunology (DMI) and University of Melbourne - Department of Microbiology and Immunology (DMI)
Downloads 118 (604,538)

Abstract:

Loading...

SARS-CoV-2, COVID-19 variants, vaccine, virus-like particles, VLP, receptor-binding domain, RBD